- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00151346
Combined Spinal-Epidural Versus Traditional Labor Epidural
Combined Spinal-Epidural Versus Traditional Labor Epidural: A Randomized, Controlled Trial Comparing Maternal and Fetal Effects
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Combined spinal-epidural anesthesia (CSE) was developed to allow excellent pain control for the pregnant woman who arrives in advanced labor and does not have much time for the anesthetic to have its effect. This has been extended recently to women in all stages of labor because of its rapid and excellent control of pain. Recent case series comparing CSE with traditional epidural have shown a slight difference in the rate of hypotension and fetal bradycardia, with the CSE technique having a higher rate of both of these side effects. This study will compare the two techniques in a prospective, randomized method.
The aim is to compare the maternal and fetal effects of two neuraxial block techniques for pain control during labor, to document blood pressure changes in upper and lower extremities pre- and post- block placement, and to document side effects (e.g. pruritus) and patient satisfaction with both techniques.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10065
- New York-Presbyterian Hospital; Weill Medical College of Cornell
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient is able to read, understand and voluntarily sign the approved informed consent form (ICF) prior to any study- specific procedure;
- Must be between 18 to 50 years of age.
- Must be carrying a singleton fetus at term.
- Must have less than a body mass index of 40.
- Must be in labor, or is having a medical induction of labor.
Exclusion Criteria:
- Patient who has chronic renal disease, pre-existing hypertension, or pre-eclampsia.
- Patient who is undergoing an elective cesarean delivery
- Patient who has a presence of non-reassuring fetal status
- Patient who has an abnormal or non-reassuring fetal heart rate (FHR) pattern
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: CSE
Subjects assigned to this group will receive "combined spinal-epidural" (CSE) to relieve pain during labor.
For CSE, subjects receive a small amount of a local anesthetic and a small amount of a narcotic pain killer directly into the spinal canal (a smaller amount than is given for traditional epidural), followed by a small amount of both of these medications that is continuously infused into the epidural space through a catheter that is left in place.
CSE is not experimental.
|
Bupivacaine 0.25% x 1 cc + Fentanyl 20 mcg, followed by infusion of Bupivacaine 0.0625% with Fentanyl 2 mcg/mL at 12 cc/hr
Other Names:
|
Active Comparator: Traditional Epidural
Subjects assigned to this group will receive "traditional epidural" to relieve pain during labor.
For the traditional epidural, subjects receive a small amount of a local anesthetic and a small amount of a narcotic pain killer into the epidural space, followed by a small amount of both of these medications that is continuously infused into the epidural space through a catheter that is left in place.
The traditional epidural is not experimental.
|
Bupivacaine 0.0625% with Fentanyl 2 mcg/mL x 15 cc, followed by infusion of Bupivacaine 0.0625% with Fentanyl 2 mcg/mL at 12 cc/hr
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Adverse fetal effects: fetal bradycardia and abnormal fetal heart rate patterns
Time Frame: during the 60 minutes after placement of analgesia
|
during the 60 minutes after placement of analgesia
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Average change in systolic blood pressure
Time Frame: during the 60 minutes after placement of analgesia
|
during the 60 minutes after placement of analgesia
|
Average change in mean blood pressure
Time Frame: during the 60 minutes after placement of analgesia
|
during the 60 minutes after placement of analgesia
|
Blood pressure differences between the upper and lower extremities
Time Frame: during the 60 minutes after placement of analgesia
|
during the 60 minutes after placement of analgesia
|
Efficacy of analgesia as rated by the visual analog pain scale
Time Frame: during the 60 minutes after analgesic placement
|
during the 60 minutes after analgesic placement
|
Pruritus
Time Frame: through the first day following placement of analgesia
|
through the first day following placement of analgesia
|
Incidence of hypotension
Time Frame: during the 60 minutes after placement of analgesia
|
during the 60 minutes after placement of analgesia
|
Patient satisfaction
Time Frame: first day following placement of analgesia
|
first day following placement of analgesia
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Daniel W. Skupski, M.D., Obstetrics & Gynecology; Weill Medical College of Cornell - New York Presbyterian Hospital
- Principal Investigator: Klaus Kjaer-Pedersen, M.D., Anesthesiology; Weill Medical College of Cornell - New York Presbyterian Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pain
- Neurologic Manifestations
- Labor Pain
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Opioid
- Narcotics
- Adjuvants, Anesthesia
- Anesthetics, Local
- Fentanyl
- Bupivacaine
Other Study ID Numbers
- 0306006204 (0603-889)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Labour Pain
-
University of British ColumbiaMassage Therapy Foundation; Holistic Health ResearchCompleted
-
Navy General Hospital, BeijingUnknown
-
Saint Thomas Hospital, PanamaCompleted
-
University of Sao PauloCompleted
-
Sunnybrook Health Sciences CentreCompleted
-
ACU Medical Technologies LtdCompleted
-
University Hospital, GhentCompletedPain Relief During LabourBelgium
-
University of BirminghamBradford Royal Infirmary; Birmingham Women's NHS Foundation Trust; Heartlands... and other collaboratorsCompleted
-
Menoufia UniversityCompleted
-
University of SkövdeCompleted
Clinical Trials on Bupivacaine and Fentanyl (for CSE)
-
Grace Lim, MD, MSCompleted
-
Augusta UniversityRecruitingLabor Pain | Obstetric PainUnited States
-
Conrad Arnfinn BjørsholCompletedPain, Postoperative | Consumption | Pruritus | Nausea and Vomiting Following Administration of Anaesthetic AgentNorway
-
University of Texas Southwestern Medical CenterCompletedPregnancyUnited States
-
Pravara Institute of Medical Sciences UniversityWithdrawnPrimigravida in Labour Pains
-
University of AlexandriaCompleted
-
Samuel Lunenfeld Research Institute, Mount Sinai...Terminated
-
Odense University HospitalCompletedPain | Lung Neoplasms | Immune SuppressionDenmark
-
National Institute for Tuberculosis and Lung Diseases...CompletedPain, Postoperative | Surgery, ThoracicPoland